pf-06730512
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 10, 2017 (NCT03146065)
Timeline
Indications
Mechanism of action
- Slit homolog 2 proteinANTAGONIST
antagonist - SLIT2
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-06730512
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03448692 | Phase 2 | Oct 3, 2018 | Pfizer |
| NCT03146065 | Phase 1 | May 10, 2017 | Pfizer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1